BGPT: Author Review: Jung-Suk Yu

Explore by Goal

Quick Explanation Copied

Author review: Jung-Suk Yu

Based on the OpenAlex profile provided (86 works; 2254 total citations; h-index 13; ORCID present for one profile) the author shows substantial scholarly impact but the provided record is non-biological and looks dominated by economics/finance topics—so biological-science “scientific strength” cannot be judged from the supplied data alone.

Long Explanation

Author Review: Jung-Suk Yu

Evidence basis: the OpenAlex author profile data you supplied (metrics + example works). No full-text paper content was provided, so I cannot assess experimental design, methods rigor, or reproducibility from biology.

Evidence provenance

Profile used: OpenAlex: Jung‐Suk Yu (A5060709676).

OpenAlex record fields (works_count, cited_by_count, h_index, counts_by_year, top works) are taken from the supplied JSON snippet.

1) Impact metrics (from supplied OpenAlex data)

These metrics reflect scholarly attention and publication record, not necessarily biological experimental quality.

Works count

Total citations

2254

h-index

Critical caveat: these indicators are genre-agnostic (can be strong in economics/finance and weak in experimental biology) and are sensitive to name disambiguation.

2) Output over time (counts_by_year)

This shows production volume by year from the supplied record.

3) Citation “hotspots” in provided top-works examples

From the supplied “top_works” list, I plot cited-by counts for the works where DOIs were present.

Note: this chart is intentionally limited to works shown in the prompt with DOIs. Many additional “top_works” entries in your snippet lacked DOI fields.

4) Scientific-domain alignment check (bio vs non-bio)

The supplied OpenAlex “topics” for this author strongly weight economics/econometrics/finance, which suggests that the author’s record—at least in this profile—may not primarily involve biological experimental science.

Red-flag for biology review: without biology-tagged publications or full texts, I can’t honestly evaluate biological rigor (controls, sample handling, assay validation, blinding, power, confounding) from metrics alone.

5) What can and cannot be concluded (skeptical assessment)

Supported by supplied evidence

There exists an OpenAlex-matched author profile with 86 works, 2254 citations, and h-index 13 for the ORCID-bearing “Jung‐Suk Yu” identity in the supplied snippet.
The supplied example “top works” include items spanning economics/finance and at least one electronics/semiconductors technology-named conference/journal item (e.g., “High Performance 45-nm SOI Technology…” in 2006).
The supplied topics distribution appears dominated by economics/econometrics/finance rather than bio/medicine.

Not supported (therefore withheld)

I cannot evaluate experimental design rigor or biological validity because no bio-relevant papers (full text or methods/results) were provided.
I cannot estimate reproducibility, data transparency, or methodological quality from citation metrics alone.
I cannot rule out name disambiguation errors (OpenAlex lists multiple similar “Yu” records), which can inflate/deflate metrics for a given identity.

Citation-geometry note: You requested inline DOI citations, but the supplied data excerpt does not include DOIs for the OpenAlex profile itself or for many of the example works—so I can’t add DOI-accurate evidence links for every metric.

6) Practical BGPT next steps (what I would fetch to do a true biology-strength review)

If you want a real bio/biomedical strength assessment, I need either:

the author’s bio/med-tagged works (DOIs or titles) from OpenAlex,
or file uploads / paper lists so I can inspect methods, controls, and results directly (not just citations).

Meta: A “science strength” evaluation for biology normally requires direct inspection of experimental methods and results. With only the supplied OpenAlex metrics, this review is necessarily domain-limited and more like a bibliometric triage.

Feedback:

Updated: March 27, 2026